Found 22 matching trials
A Randomized Controlled Trial of Eculizumab in AQP4 Antibody-positive Participants With NMO (PREVENT Study)
PHASE3The objectives of this time-to-event study were to assess the efficacy and ...
Location
Mayo Clinic Arizona
Human Challenge Study to Evaluate the Efficacy of MV-012-968 Vaccine
PHASE2The purpose of this research study is to evaluate whether the investigation...
Location
hVIVO Services Ltd
STRIDE - STimulating Immune Response In aDvanced brEast Cancer
PHASE3EMD Serono has decided to permanently terminate the trial EMR 200038-010 (S...
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
PHASE2Cervical cancer is associated with Human Papilloma Virus. About 57% of cerv...
Location
New Horizons Women's Care, LLC
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
PHASE3The purpose of this study is to determine the safety and efficacy of MDX-01...
Location
Arizona Cancer Center
Depletion of Serum Amyloid P Component to Enhance the Immune Response to DNA Vaccination
PHASE1This is a clinical proof-of-concept (PoC) study of DNA vaccination after SA...
Location
National Amyloidosis Centre
WJMSCs Anti-inflammatory Therapy in Coronary Artery Disease
PHASE2As biologic, epidemiologic, and clinical trial data have demonstrated, infl...
Location
Multiple Locations
Radiation Therapy Plus Temozolomide and Pembrolizumab With and Without HSPPC-96 in Newly Diagnosed Glioblastoma (GBM)
PHASE2Background:
Glioblastoma (GBM) refers to a specific kind of brain cancer c...
Location
National Institutes of Health Clinical Center
Immune Response to PNEUMOVAX 23 in Healthy Adults Receiving Efgartigimod IV
PHASE1This is a randomized, open-label, placebo-controlled phase 1 study in healt...
Location
Investigator site 1
GVAX vs. Placebo for MDS/AML After Allo HSCT
PHASE2This research study is a Phase II clinical trial. Phase II clinical trials ...
Location
Massachusetts General Hospital